Two common drugs found effective against Covid in early testing


PTI, Dec 10, 2021, 12:23 PM IST

Source: NYTimes

Washington DC: Two over-the-counter drugs have been found to inhibit the replication of SARS-CoV-2, the virus that causes COVID-19, in preliminary tests, according to a study.

Researchers from the University of Florida in the US noted that the combination includes diphenhydramine, an antihistamine used for allergy symptoms.

When paired with lactoferrin, a protein found in cow and human milk, the compounds were found to hinder SARS-CoV-2 during tests in monkey cells and human lung cells, they said.

Lactoferrin is commonly used as a supplement to treat stomach and intestinal ulcers, among other uses, according to the researchers.

”We found out why certain drugs are active against the virus that causes COVID-19. Then, we found an antiviral combination that can be effective, economical and has a long history of safety,” said David A Ostrov, an associate professor at the University of Florida.

In lab tests on human and monkey cells, the combination of drugs was particularly potent, the researchers said.

Individually, the two compounds each inhibited SARS-CoV-2 virus replication by about 30 per cent, they said, adding that together, they reduced virus replication by 99 per cent.

The findings, published in the journal Pathogens, are a first step in developing a formulation that could be used to accelerate COVID-19 recovery.

Additional research into the compounds’ effectiveness for COVID-19 prevention is already underway in mouse models, the researchers said.

To establish their findings, they focused on proteins expressed in human cells known as sigma receptors.

In COVID-19 cases, the virus ”hijacks” stress-response machinery, including sigma receptors, in order to replicate in the body, according to the researchers.

Interfering with that signalling appears to be the key to inhibiting the virus’s potency, they said.

”We now know the detailed mechanism of how certain drugs inhibit SARS-CoV-2 infection,” Ostrov said.

Data from the experiments show that a highly specific sigma receptor binding drug candidate and formulated combinations of over-the-counter products have the potential to inhibit virus infection and decrease recovery time from COVID-19, the researchers said.

While the findings are encouraging, Ostrov cautions against self-medicating with either diphenhydramine or lactoferrin as a COVID-19 prevention or treatment.

The type of lactoferrin used in the research differs slightly from the type that is commonly available to consumers, he added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

BJP stages protest against Karnataka govt over Waqf properties row

Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady

India crawl to 51 for 4 after losing top-order

Nursing student suicide: Three students arrested in Kerala

Nadda’s letter to Kharge full of falsehoods: Cong

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Related Articles More

10 month baby gets new heart, new life

World COPD Day: Know your lung function

As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all

World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness

World Diabetes Day: An overview of types of diabetes

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

SC notice to Gujarat govt on Asaram’s plea seeking suspension of sentence in 2013 rape case

BJP stages protest against Karnataka govt over Waqf properties row

US charges against Adani, 7 others could lead to arrest warrants, extradition bid: attorney

Youth attempts suicide after being humiliated in public for wearing ripped jeans in Belthangady

Baku climate talks: The ‘X’ factor that could determine future of Global South

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.